Feasibility study: Targeting post cancer fatigue among women and men with breast cancer using acupuncture compared with treatment as usual

Western Sydney University0 个研究点目标入组 20 人开始时间: 2015年10月29日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•1) diagnosis of stage I, II, or III BC, who have completed breast surgery, adjuvant or neo-adjuvant chemotherapy and/or adjuvant radiotherapy between one month to 2 years prior to enrolment and who have not developed recurrent disease in the intervening period between diagnosis and study recruitment.
•2) Taking adjuvant endocrine therapy and trastuzumab (Herceptin) are eligible
•3) Ongoing cancer related fatigue, defined as a score of 4 or more on the fatigue sub scale of the Somatic and Psychological Health Report (SPHERE) questionnaire
•4) Normal coagulation coagulation studies: PT, APTT, INR at baseline or within the previous 1 month.
•5) Adequate haematological parameters at baseline or within the previous 1 month: Hb greater than 100, ANC greater than 1.0, Platelet count greater than 150.

•1) Co-morbid medical conditions expected to cause ongoing fatigue, (e.g.co-morbidity significant anaemia (defined as Hb less than 100) or thyroid disease) as assessed by the investigator.
•2) Current use of acupuncture.
•3) Needle phobia.
•4) Concurrent treatment with medication interfering with blood clotting or bleeding time, including heparin and fractionated heparin, vitamin K antagonists, direct thrombin inhibiitors, factor Xa inhibitors, and antiplatelet agents.
•5) Life expectancy less than six months.
•6) Plan for major surgery during the time of the study e.g. breast reconstruction or re-excision.
•7) History of other malignany within 5 years of recruitment, other than CIN of cervix or non-melanomatous skin cancers.

发起方